In the first of a two-part series with TB and HIV experts at the Bill & Melinda Gates Foundation, Dr. Stefano Bertozzi, director of HIV and tuberculosis programs at the Foundation, gives his thoughts on what lies ahead this year in HIV and TB building on key developments from the past year and a half. In his role, Dr. Bertozzi oversees grants in HIV vaccine development, biomedical prevention research, diagnostics development and resistance monitoring, and strategies for introduction and scaling-up of interventions. He has held past leadership roles at UNAIDS, the World Health Organization, the World Bank, and the National Institute of Public Health (INSP) in Mexico.
Retaining people with HIV in care and treatment for the virus, as well as successful efforts to re-engage patients who have been in care but no […]
Tracing contacts of people confirmed to be sick with tuberculosis and making preventive treatment available to those at risk for the disease, could halve current numbers […]
WHO report on global antibiotic resistance highlights growing threats in the face of surveillance gaps
Surveillance data from 22 countries show some of the world’s most common and potentially deadly infections gaining ground globally against the antibiotics used to treat them, […]
White House budget recognizes global health threats with words, but not dollars with massive cuts to HHS, State Department, USAID
“U.S. efforts to control the HIV/AIDS epidemic are a direct reflection of U.S. leadership abroad and the goodwill, compassion, and generosity of the American people.” President’s […]